Clinical Trials · NCT06533527
Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy
CompletedPhase 4Tirzepatide (Approved)Semaglutide (Approved)Liraglutide (Approved)Dulaglutide (Approved)
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- The Cleveland Clinic
- Enrollment
- 69
- Start date
- Jul 2024
- Locations
- 2 sites, United States
- Primary endpoint
- Presence of RGV (Residual Gastric Volume) in Stomach